Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-22
DOI
10.1038/s41467-019-13331-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
- (2019) Suzanne L. Topalian et al. JAMA Oncology
- Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
- (2018) E E Vokes et al. ANNALS OF ONCOLOGY
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion
- (2018) Liwen Li et al. OncoImmunology
- Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation
- (2017) Jingjiao Zhou et al. Cancer Immunology Research
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
- (2016) Satyendra C. Tripathi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer
- (2015) Z. Qu et al. CANCER RESEARCH
- Oncovirus Kaposi Sarcoma Herpesvirus (KSHV) Represses Tumor Suppressor PDLIM2 to Persistently Activate Nuclear Factor κB (NF-κB) and STAT3 Transcription Factors for Tumorigenesis and Tumor Maintenance
- (2015) Fan Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
- (2015) Matthew G Oser et al. LANCET ONCOLOGY
- NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function
- (2015) F Sun et al. ONCOGENE
- Human T-Cell Leukemia Virus Type I-Mediated Repression of PDZ-LIM Domain-Containing Protein 2 Involves DNA Methylation But Independent of the Viral Oncoprotein Tax
- (2015) Pengrong Yan et al. NEOPLASIA
- Loss of Epithelial RelA Results in Deregulated Intestinal Proliferative/Apoptotic Homeostasis and Susceptibility to Inflammation
- (2014) K. A. Steinbrecher et al. JOURNAL OF IMMUNOLOGY
- Differential roles of STAT3 in the initiation and growth of lung cancer
- (2014) J Zhou et al. ONCOGENE
- Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
- (2014) Kate D. Sutherland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 Target Genes Relevant to Human Cancers
- (2014) Richard Carpenter et al. Cancers
- Mouse models for lung cancer
- (2013) Min-chul Kwon et al. Molecular Oncology
- PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion and anti-migration and -invasion activity of vitamin D
- (2013) E Vanoirbeek et al. ONCOGENE
- Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma
- (2013) S. Mainardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease
- (2013) Zhaoxia Qu et al. Cell and Bioscience
- Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- (2012) J. Botling et al. CLINICAL CANCER RESEARCH
- Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma
- (2012) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- PDLIM2 Inhibits T Helper 17 Cell Development and Granulomatous Inflammation Through Degradation of STAT3
- (2011) T. Tanaka et al. Science Signaling
- Human T-Cell Lymphotropic Virus: A Model of NF-κB-Associated Tumorigenesis
- (2011) Zhaoxia Qu et al. Viruses-Basel
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling
- (2011) Zhaoxia Qu et al. Cell and Bioscience
- The tumor suppressor gene WWOX links the canonical and noncanonical NF- B pathways in HTLV-I Tax-mediated tumorigenesis
- (2010) J. Fu et al. BLOOD
- NF- B Fans the Flames of Lung Carcinogenesis
- (2010) K. K. Wong et al. Cancer Prevention Research
- Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
- (2010) Daniela S. Bassères et al. CANCER RESEARCH
- DNA Methylation-Dependent Repression of PDZ-LIM Domain-Containing Protein 2 in Colon Cancer and Its Role as a Potential Therapeutic Target
- (2010) Z. Qu et al. CANCER RESEARCH
- Epigenetic Repression of PDZ-LIM Domain-containing Protein 2
- (2010) Zhaoxia Qu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
- (2010) A McGarry Houghton et al. NATURE MEDICINE
- Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis
- (2010) J Fu et al. ONCOGENE
- PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation
- (2009) P. Yan et al. BLOOD
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
- (2009) Etienne Meylan et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More